Post hoc analysis of phase 3 JCOG0802 in 298 patients with stage IA NSCLC ≤2 cm with invasive features: segmentectomy showed a non-significant trend to better overall survival vs lobectomy (HR 0.657; p=0.09) but more locoregional relapse (HR 2.234).
Secondary analysisn = 298
Katsumata et al. Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L